New York · 2025 Regular Session · Bill
A 5029: Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 5029 is a bill introduced in the New York House on February 11, 2025. According to its official title, it concerns: Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors. Primary sponsor: Jonathan Jacobson (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HIGHER EDUCATION.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jonathan Jacobson | Primary sponsor | Democratic | House | 104 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HIGHER EDUCATION
- REFERRED TO HIGHER EDUCATION